Actively Recruiting
GEKO Venous Thromboembolism Prevention Study
Led by Firstkind Ltd · Updated on 2025-03-04
1200
Participants Needed
18
Research Sites
103 weeks
Total Duration
On this page
Sponsors
F
Firstkind Ltd
Lead Sponsor
N
National Institute for Health Research, United Kingdom
Collaborating Sponsor
AI-Summary
What this Trial Is About
This multicentre, randomised geko™ venous thromboembolism (VTE) prevention study will prospectively collect clinical data on VTE occurrences in immobile patients after stroke, who will be randomised, on a 1:1 allocation, to receive either standard of care (Intermittent Pneumatic Compression) or geko™ neuromuscular electrostimulation device. The aim is to assess the prevention of VTE during a follow-up period of 90 days (three months) post-randomisation.
CONDITIONS
Official Title
GEKO Venous Thromboembolism Prevention Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Clinical diagnosis of acute stroke (WHO criteria)
- Within 36 hours of symptom onset
- Unable to get up from a chair or out of bed and walk to the toilet without help from another person
You will not qualify if you...
- Unable to give consent or no suitable consultee available
- Unwitnessed stroke onset with a long time lying on the floor before admission
- Visible deep vein thrombosis at screening
- Expected to need palliative care within 14 days
- Lives outside the local hospital area and likely to be transferred elsewhere
- Participation in another clinical trial within the past 3 months (unless approved by Chief Investigator)
- Allergy to hydrogel in the geko17; device
- Severe peripheral vascular disease
- Large leg ulcers requiring extensive bandaging
- Severe swelling (oedema)
- Leg deformities preventing proper device fitting
- Uncontrolled congestive heart failure
- Pregnancy
- Single or double leg amputations
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 18 locations
1
West Suffolk Hospital
Bury St Edmunds, Suffolk, United Kingdom, IP29 5DN
Actively Recruiting
2
Royal United Hospital
Bath, United Kingdom, BA1 3NG
Actively Recruiting
3
Queen Elizabeth Hospital Birmingham
Birmingham, United Kingdom, B15 2GW
Actively Recruiting
4
The Royal Bournemouth Hospital
Bournemouth, United Kingdom, BH7 7DW
Actively Recruiting
5
Fairfield General Hospital
Bury, United Kingdom, BL9 7TD
Actively Recruiting
6
Addenbrooke's Hospital
Cambridge, United Kingdom, CB2 0QQ
Actively Recruiting
7
Kent and Canterbury Hospital
Canterbury, United Kingdom, CT1 3NG
Not Yet Recruiting
8
Countess of Chester Hospital
Chester, United Kingdom, CH2 1UL
Actively Recruiting
9
Whiston Hospital
Liverpool, United Kingdom, L35 5DR
Actively Recruiting
10
Northwick Park Hospital
London, United Kingdom, HA1 3UJ
Actively Recruiting
11
King's College Hospital
London, United Kingdom, SE5 9RS
Actively Recruiting
12
Milton Keynes University Hospital
Milton Keynes, United Kingdom, MK6 5LD
Actively Recruiting
13
Queen's Medical Centre
Nottingham, United Kingdom, NG7 2UH
Actively Recruiting
14
Salford Royal Hospital
Salford, United Kingdom, M6 8HD
Actively Recruiting
15
Stepping Hill Hospital
Stockport, United Kingdom, SK2 7JE
Actively Recruiting
16
Royal Stoke University Hospital
Stoke-on-Trent, United Kingdom, ST4 6QG
Actively Recruiting
17
New Cross Hospital
Wolverhampton, United Kingdom, WV10 0QP
Actively Recruiting
18
Yeovil Hospital
Yeovil, United Kingdom, BA21 4AT
Actively Recruiting
Research Team
K
Kieron Day, DPhil
CONTACT
W
Wing To, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here